Literature DB >> 1985460

A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa.

C F Inglehearn1, R Bashir, D H Lester, M Jay, A C Bird, S S Bhattacharya.   

Abstract

Autosomal dominant retinitis pigmentosa (ADRP) has recently been linked to locus D3S47 (probe C17), with no recombination, in a single large Irish family. Other ADRP pedigrees have shown linkage at zero recombination, linkage with recombination, and no linkage, demonstrating genetic heterogeneity. The gene encoding rhodopsin, the rod photoreceptor pigment, is closely linked to locus D3S47 on chromosome 3q. A point mutation changing a conserved proline to histidine in the 23d codon of the gene has been demonstrated in affected members of one ADRP family and in 17 of 148 unrelated ADRP patients. We have sequenced the rhodopsin gene in a C17-linked ADRP family and have identified in the 4th exon and in-frame 3-bp deletion which deletes one of the two isoleucine monomers at codons 255 and 256. This mutation was not found in 30 other unrelated ADRP families. The deletion has arisen in the sequence TCATCATCAT, deleting one of a run of three x 3-bp repeats. The mechanism by which this occurred may be similar to that which creates length variation in so-called mini- and microsatellites. Thus ADRP is an extremely heterogeneous disorder which can result from a range of defects in rhodopsin and which can have a locus or loci elsewhere in the genome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985460      PMCID: PMC1682750     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins.

Authors:  B K Kobilka; T Frielle; S Collins; T Yang-Feng; T S Kobilka; U Francke; R J Lefkowitz; M G Caron
Journal:  Nature       Date:  1987 Sep 3-9       Impact factor: 49.962

2.  Molecular genetics of inherited variation in human color vision.

Authors:  J Nathans; T P Piantanida; R L Eddy; T B Shows; D S Hogness
Journal:  Science       Date:  1986-04-11       Impact factor: 47.728

3.  Dominant retinitis pigmentosa with reduced penetrance.

Authors:  E L Berson; P Gouras; R D Gunkel; N C Myrianthopoulos
Journal:  Arch Ophthalmol       Date:  1969-02

4.  A clinical, psychophysical, and electroretinographic survey of patients with autosomal dominant retinitis pigmentosa.

Authors:  A L Lyness; W Ernst; M P Quinlan; G M Clover; G B Arden; R M Carter; A C Bird; J A Parker
Journal:  Br J Ophthalmol       Date:  1985-05       Impact factor: 4.638

5.  5'-32P labeling of RNA and DNA restriction fragments.

Authors:  G Chaconas; J H van de Sande
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

Review 6.  Molecular biology of the visual pigments.

Authors:  M L Applebury; P A Hargrave
Journal:  Vision Res       Date:  1986       Impact factor: 1.886

7.  Prolonged rod dark adaptation in retinitis pigmentosa.

Authors:  K R Alexander; G A Fishman
Journal:  Br J Ophthalmol       Date:  1984-08       Impact factor: 4.638

8.  Rod sensitivity relative to cone sensitivity in retinitis pigmentosa.

Authors:  R W Massof; D Finkelstein
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-03       Impact factor: 4.799

9.  Retinitis pigmentosa.

Authors:  S Merin; E Auerbach
Journal:  Surv Ophthalmol       Date:  1976 Mar-Apr       Impact factor: 6.048

10.  A study of retinitis pigmentosa in the City of Birmingham. II Clinical and genetic heterogeneity.

Authors:  S Bundey; S J Crews
Journal:  J Med Genet       Date:  1984-12       Impact factor: 6.318

View more
  26 in total

1.  Recurrent 3-bp deletion at codon 255/256 of the rhodopsin gene in a German pedigree with autosomal dominant retinitis pigmentosa.

Authors:  A Artlich; M Horn; B Lorenz; S Bhattacharga; A Gal
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

2.  Clinical and ERG data in a family with autosomal dominant RP and Pro-347-Arg mutation in the rhodopsin gene.

Authors:  G Niemeyer; P Trüb; A Schinzel; A Gal
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

3.  Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa.

Authors:  C H Sung; B G Schneider; N Agarwal; D S Papermaster; J Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

4.  Isolation of a candidate gene for choroideremia.

Authors:  D E Merry; P A Jänne; J E Landers; R A Lewis; R L Nussbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 5.  Finding and interpreting genetic variations that are important to ophthalmologists.

Authors:  Edwin M Stone
Journal:  Trans Am Ophthalmol Soc       Date:  2003

6.  Three new mutations in patients with myophosphorylase deficiency (McArdle disease).

Authors:  S Tsujino; S Shanske; I Nonaka; Y Eto; J R Mendell; G M Fenichel; S DiMauro
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

7.  Localisation of the human blue cone pigment gene to chromosome band 7q31.3-32.

Authors:  J Fitzgibbon; B Appukuttan; S Gayther; D Wells; J Delhanty; D M Hunt
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

Review 8.  A Systematic Review and Meta-Analyses of Interventional Clinical Trial Studies for Gene Therapies for the Inherited Retinal Degenerations (IRDs).

Authors:  Gearóid P Tuohy; Roly Megaw
Journal:  Biomolecules       Date:  2021-05-19

9.  Autosomal dominant retinitis pigmentosa with rhodopsin, valine-345-methionine.

Authors:  E L Berson; M A Sandberg; T P Dryja
Journal:  Trans Am Ophthalmol Soc       Date:  1991

10.  Autosomal dominant retinitis pigmentosa (adRP; RP6): cosegregation of RP6 and the peripherin-RDS locus in a late-onset family of Irish origin.

Authors:  S A Jordan; G J Farrar; R Kumar-Singh; P Kenna; M M Humphries; V Allamand; E M Sharp; P Humphries
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.